Valuation Profarma Distribuidora de Produtos Farmacêuticos S.A.

Stocks

Market Closed - Sao Paulo 01:33:00 30/10/2026 am IST			5-day change	1st Jan Change
6.600 ^BRL	-6.78%		-29.49%	-27.71%

30/07	Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07/05	Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	747.9	723.4	450	747.9	795.7	1,119
Change	-	-3.28%	-37.8%	66.21%	6.39%	40.68%
Enterprise Value (EV) ¹	1,277	1,482	1,291	1,698	1,813	2,286
Change	-	16.05%	-12.88%	31.53%	6.77%	26.1%
P/E	14.3x	9.25x	5.56x	10.6x	6.95x	9.42x
PBR	0.71x	0.67x	0.38x	0.6x	0.61x	0.83x
PEG	-	0.2x	1.62x	-0.8x	0.1x	2.46x
Capitalization / Revenue	0.14x	0.11x	0.06x	0.09x	0.08x	0.1x
EV / Revenue	0.23x	0.23x	0.17x	0.2x	0.18x	0.2x
EV / EBITDA	8.52x	9.11x	4.54x	5.74x	5.3x	5.65x
EV / EBIT	9.95x	10.9x	5.09x	6.5x	6.05x	6.53x
EV / FCF	-50.4x	-136x	-22.6x	-101x	11.3x	34.7x
FCF Yield	-1.98%	-0.73%	-4.42%	-0.99%	8.82%	2.88%
Dividend per Share ²	-	0.2706	0.1733	0.3858	0.575	-
Rate of return	-	4.59%	4.72%	6.32%	8.86%	-
EPS ²	0.4268	0.6377	0.6596	0.574	0.934	0.9697
Distribution rate	-	42.4%	26.3%	67.2%	61.6%	-
Net sales ¹	5,481	6,413	7,816	8,662	10,154	11,451
EBITDA ¹	149.9	162.7	284.2	295.6	342.1	404.5
EBIT ¹	128.3	136.3	253.8	261.1	299.7	350.1
Net income ¹	52.33	78.19	80.87	70.4	114.6	118.9
Net Debt ¹	528.9	758.4	840.9	950	1,017	1,167
Reference price ²	6.100	5.900	3.670	6.100	6.490	9.130
Nbr of stocks (in thousands)	1,22,611	1,22,611	1,22,611	1,22,611	1,22,611	1,22,611
Announcement Date	16/03/21	16/03/22	15/03/23	07/03/24	18/03/25	17/03/26

¹BRL in Million²BRL

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
PROFARMA DISTRIBUIDORA DE PRODUTOS FARMACÊUTICOS S.A.	-	-	-	-	16Cr
ELI LILLY AND COMPANY	37.84x	13.27x	28.43x	0.53%	1,14800Cr
JOHNSON & JOHNSON	39.67x	6.67x	18.75x	1.97%	65TCr
ABBVIE INC.	37.4x	8.39x	17.35x	2.4%	51TCr
ROCHE HOLDING AG	21.45x	5.21x	12.93x	2.51%	38TCr
MERCK & CO., INC.	102.73x	5.76x	24.72x	2.42%	35TCr
NOVARTIS AG	21.89x	5.76x	13.88x	2.85%	29TCr
ASTRAZENECA PLC	22.21x	4.49x	12.82x	1.97%	26TCr
AMGEN INC.	28.66x	7.33x	13.12x	2.23%	24TCr
GILEAD SCIENCES, INC.	-45.79x	7.11x	27.55x	2.07%	20TCr
Average	29.56x	7.11x	18.84x	2.11%	40.37TCr
Weighted average by Cap.	35.29x	8.40x	20.64x	1.79%